In-depth interviews were conducted with CEOs, sales and marketing directors, other innovation and
technology directors, and executives from various key organizations operating in the contrast injector
market.
? By Company Type: Tier 1: 10%, Tier 2: 63%, Tier 3: 27%
? By Designation: Director Level: 19%, C-level: 28%, Others: 53%
? By Region: North America: 27%, Europe: 27%, APAC: 30%, RoW: 16%
Key players in the global contrast injector market include Bracco Imaging S.p.A (Italy), Bayer
HealthCare (Germany), Guerbet Group (France), GE Healthcare (U.S.), ulrich GmbH & Co. KG,
(Germany), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device Technology Co., Ltd.
(China), Apollo RT Co., Ltd. (China), VIVID IMAGING (China), and AngioDynamics(U.S.)
Research Coverage:
The report provides a picture of the contrast injector market across different industry verticals and
regions. It aims at estimating the market size and future growth potential of this market across
different segments such as by product, application, and region. Furthermore, the report also includes
an in-depth competitive analysis of the key players in the market along with their company profiles,
recent developments, product pipeline, and key market strategies.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse
of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report
could use any one or a combination of the below-mentioned five strategies (market penetration,
product development/innovation, market development, market diversification, and competitive
assessment) for strengthening their market shares.
The report provides insights on the following pointers: